Marketing Sexual Wellness Services Without Triggering Compliance or Platform Restrictions
The field of sexual wellness is experiencing significant growth. The worldwide market was valued at $51.17 billion in 2025 and is anticipated to attain $55.66 billion in 2026, demonstrating a compound annual growth rate of 8.8% [1].
Nevertheless, marketing these services introduces distinct challenges. Advertisers are required to comply with FDA regulations, platform-specific content policies, and HIPAA privacy standards. Numerous well-intentioned campaigns have been declined, restricted, or penalized due to violations of rules that are enforced inconsistently.
FDA Regulations and Claims Substantiation
The Food and Drug Administration (FDA) does not maintain a definitive list of approved claims for intimate wellness products, nor does it specify the requisite level of supporting evidence. This regulatory omission creates uncertainty. While general wellness products are subject to fewer restrictions, any product asserting to treat a medical condition—such as erectile dysfunction or hypoactive sexual desire disorder—necessitates proper FDA clearance.
The Food and Drug Administration (FDA) recently issued a warning letter concerning a social media promotion for Addyi, a prescription medication indicated for female sexual dysfunction. The agency concluded that the post broadly advertised the drug for women’s sexual health, failed to include the necessary safety information, and conveyed the impression that the product is safe for a larger population than what has been officially approved. [4]
The principle is clear: prescription medications are not permitted to be marketed for off-label applications. Even educational material must refrain from crossing into promotional activities.
The FDA’s 2016 framework continues to serve as the benchmark for general wellness products. Such products must be non-invasive, pose no safety risks, and be designated solely for general wellness purposes, explicitly not for the treatment of specific diseases or medical conditions [5].
Marketing materials must remain consistent with the stated intended use.
Platform-Specific Advertising Policies
Google, Meta, and other platforms uphold specific policies concerning sexual wellness advertising. It is imperative to understand these policies before initiating any campaign.
Google’s revised Sexual Health and Wellness Policy, effective from October 2024, authorizes advertisements for erectile dysfunction and hypoactive sexual desire disorder on the Display Network and YouTube, subject to specific conditions: advertisements must not accentuate sexual gratification or enhancement, must exclude sexually suggestive content, and must target audiences aged 18 and above [6]. Additionally, advertisers must obtain healthcare product certification before using prescription-medication terminology in their advertisements [7].
Google’s Personalized Advertising Policy prohibits targeting users based on sensitive health conditions, including sexual health [8]. This restriction applies even when targeting is based on inferred interests rather than explicit data. In 2025, Google also blocked advertisements for a government-funded STI awareness campaign, classifying them as “adult content,” a decision that sexual health organizations contended undermined public health initiatives [9].
Meta’s policies differentiate between sexual health education and content related to sexual pleasure. Advertisements endorsing sexual and reproductive health or wellness products, including contraception and family planning, are required to target audiences aged 18 or older and must refrain from emphasizing sexual pleasure [10].
Nevertheless, enforcement remains inconsistent. The Center for Intimacy Justice submitted a complaint to the Federal Trade Commission (FTC), asserting that Meta systematically discriminates against sexual health products targeted at women compared to those aimed at men, leading to a disproportionate number of advertisement rejections [11].
Reports indicate that advertisements about women’s health issues, such as menopause, fertility, and pelvic pain, are frequently flagged as inappropriate, whereas advertisements for male sexual wellness products encounter fewer restrictions [12].
For example, the telehealth provider Midi Health reported that its advertisements mentioning “menopause” were repeatedly rejected despite employing medically accurate language [13].
HIPAA Compliance in Marketing
HIPAA imposes stringent regulations on marketing communications involving protected health information (PHI). According to the Privacy Rule, covered entities must obtain written authorization before using or disclosing PHI for marketing purposes, with certain limited exceptions [14]. The two recognized exceptions encompass face-to-face communications and promotional gifts of nominal value [15].
This matter is of considerable significance for email marketing, retargeting campaigns, and any advertising that depends on patient data. Should a patient complete an intake form for sexual wellness services, such information cannot be utilized for targeted advertising without explicit consent.
Even patient testimonials posted on social media do not waive HIPAA protections; identifying a patient in marketing materials without signed authorization constitutes a violation [16].
The repercussions of non-compliance are considerable. Violations of HIPAA may incur fines ranging from $100 to $50,000 per violation, and breaches of platform policy may lead to account suspension [17].
Practical Strategies for Compliant Marketing
Despite these challenges, effective marketing is possible. Several strategies help maintain compliance while reaching target audiences.
- Lead with education rather than promotion. Information that elucidates conditions, treatment options, and anticipated outcomes can foster compliance and cultivate trust. Educational content is less likely to trigger platform restrictions and more likely to attract patients who are researching their options.
- Use condition-based keywords rather than treatment-specific terms. A webpage optimized for the keyword “low libido causes” is less likely to encounter restrictions compared to one optimized for “buy libido pills.” This strategy also corresponds to typical patient search behavior. Research on direct-to-consumer telehealth services has indicated that patients frequently initiate their inquiries with symptoms rather than specific treatments, thereby rendering educational content an effective initial approach [18].
- Implement age-gating. All advertisements related to sexual wellness must be directed exclusively towards users aged 18 or older. It is generally a platform requirement to enforce this, and failing to apply appropriate age restrictions may result in the rejection of advertisements.
- Use separate landing pages for different audiences. Educational content intended for general audiences may adopt a broader scope, whereas treatment-specific pages are expected to incorporate appropriate disclaimers and compliance language.
- Document all claims substantiation. Maintain records of scientific studies, customer surveys, or third-party certifications that support any claims made in marketing materials. This documentation is essential if regulatory questions arise.
Gender Bias in Platform Enforcement
Orthopedic practices managing knee osteoarthritis, rotator cuff tears, or plantar fasciitis may utilize case studies to demonstrate the effectiveness of non-surgical interventions. Patients contemplating PRP or shockwave therapy are interested in reviewing before-and-after outcomes for comparable conditions.
Patient case narratives should describe the patient’s baseline pain level, functional limitations, treatment received, and post-treatment status. Functional outcome documentation provides objective evidence beyond visual appearance. This may include:
- Walking distance,
- Range of motion,
- Heart and breathing rate
- Return to sport, and more.
For clinics providing RegenOMedix IRB-approved stem cell protocols for orthopedic indications, documented case outcomes may be presented within an IRB study framework, thereby enhancing scientific credibility beyond conventional advertising [11].
Implementation for Hair Restoration Clinics
A substantial challenge in the marketing of sexual wellness products is the inconsistency in platform policies regarding male and female sexual health content. Data indicate that advertisements for erectile dysfunction treatments encounter relatively minimal restrictions, whereas advertisements concerning menopause, female sexual dysfunction, or pelvic health are often subject to being flagged [19].
To address this discrepancy, advertisers ought to consider implementing several strategies. Employing clinically precise terminology (such as “hypoactive sexual desire disorder” instead of “low libido”) may diminish the probability of eliciting scrutiny.
Including educational context about the condition’s medical nature can help distinguish the content from purely pleasure-focused material. Submitting ads for manual review through platform support channels may also be necessary when automated systems produce false positives.
Conclusion
Marketing sexual wellness services requires a comprehensive compliance strategy that accounts for FDA regulations, platform policies, and HIPAA requirements. The regulatory landscape remains fragmented, with enforcement often inconsistent, especially concerning gender-based disparities in content moderation.
However, the market opportunity is substantial, and compliant marketing is achievable. By focusing on education, using precise medical terminology, implementing appropriate age restrictions, and documenting all substantiation for claims, sexual wellness providers can reach their target audiences without triggering regulatory or platform penalties.
Networld Online develops compliant digital marketing strategies for healthcare providers, including those offering sexual wellness services. Contact Networld Online to discuss a marketing approach tailored to your services and target markets.
References
- Research and Markets. (2025). Sexual Wellness Global Market Report 2025-2026. https://www.researchandmarkets.com
- FDA General Wellness Policy for Low Risk Devices. (2016). Guidance for Industry and Food and Drug Administration Staff. U.S. Department of Health and Human Services.
- Winsome Marketing. (2025). Navigating FDA Regulations: A Marketing Guide for FemTech Startups.
- LexBlog. (2025). FDA Ratchets Enforcement on Social Media Promotion in New Warning Letter. June 11, 2025.
- Hooper Lundy. (2026). FDA’s New Digital Health Guidance Signal Shift for Wellness Devices and CDS. January 9, 2026.
- Google Ads Help. (2024). Sexual health & wellness policy. October 2024.
- Inceptly. (2024). Google’s New “Sexual Health & Wellness” Policy: Key Updates for Advertisers. October 30, 2024.
- Google Ads Help. (2025). Update to the Personalized Advertising Policy. May 2025.
- The Guardian. (2025). Google blocked STI-awareness ads as ‘adult content’, Senate estimates hear. October 9, 2025.
- Meta Transparency Center. (2025). Health and wellness policy.
- Center for Intimacy Justice. (2023). FTC Complaint Regarding Meta’s Discriminatory Advertising Policies. July 2023.
- AdExchanger. (2025). The ‘Taboo’ Of Women’s Health Care Advertising Complicates Access To Treatment. July 9, 2025.
- MediaPost. (2025). HerMD: Its Ads Mentioning ‘Menopause’ Were Once Rejected As ‘Porn’.
- U.S. Department of Health and Human Services. (2025). Marketing. HIPAA Privacy Rule Guidance.
- calHIPAA. (2025). What are the HIPAA Guidelines for Healthcare Marketing? August 3, 2025.
- The HIPAA E-Tool. (2025). Avoid HIPAA Violations in Marketing: 3 Simple Steps. September 15, 2025.
- Rank and Rejuvenate. (2025). HIPAA & Advertising for Med Spas: What You Can and Cannot Say. September 7, 2025.
- Cureus. (2025). Navigating the Landscape of Direct-to-Consumer Telehealth Services. February 17, 2025. https://pmc.ncbi.nlm.nih.gov
- Marketing Interactive. (2026). Facebook and Instagram are accused of rejecting women’s health ads. March 26, 2026.
Bruce Bertman, CEO of Zizion Group LLC & Networld Online, Inc.
Bruce Bertman, CEO of Zizion Group LLC and Networld Online, Inc., is a distinguished marketing professional with a career spanning work with AT&T, IBM, Inacomp Computer Centers, and numerous charitable organizations. Based in Boca Raton, Florida, he leads Zizion’s global medical device distribution operations and represents the company at international events. As a business innovator and speaker, Bertman launched three companies and guided hundreds of clients to sales success. As CEO of Networld Online, he’s a respected digital marketing leader and visionary who empowers clients and partners to succeed.
Table of Contents
Recent Posts